Compatibility with the biological host, cleanliness and intrinsic reliability are all crucially affected by the  surface properties of materials used inside the body or in contact with skin surfaces  for prostheses, implants or drug delivery. Low temperature plasma processing technologies, developed in association with Portal Medical, enable polymer surfaces to be modified in a controlled, clean and precise way to create biocompatible and anti-microbial environments and surfaces.   Surfaces can be solid plastic, sheet or fibre. All  can be enhanced to change lubricity, adhesion, permeability, biocompatibility and wetting  without substrate heating, surface damage or undesirable secondary oxidation. Full traceability and compliance with cGMP standardsis included in the operating process.

Sterile processing
Plasma surface modification processing opens up new opportunities for bioengineering, with plastics and other materials that melt at low temperatures or cannot withstand autoclaving, the aggressive  environments of ethylene oxide or gamma irradiation. It can also be applied to ceramic and metal components for etching, super finishing, cleaning  and other surface modifications designed to aid lubricity, adhesion or other aspects of biocompatibility and chemical processes, such as polymerisation and cross-linking.

Plasma processing applications for medical devices
■ Polymer and composite surfaces used in prostheses such as knee and hip joints.
■ 
Delicate fabrics such as wicks to draw blood or other body fluids into sensors, for example, blood glucose sensors.
■ Wound-care materials such as polyurethane film and foams and medical gauze.
■ Drug-delivery systems such as inhalers and other items such as stents for cardiac care and fabric stents used to repair aneurysms can be made more biocompatible or safely enhanced to meet desired performance levels.

Thermal processing
Tecvac offers a complete range of thermal processing services  including heat treatment for advanced metallics,  and vacuum brazing for assembly of complex metal components . These  processes are backed by a full suite of  analytical services including electron microscopy and X-ray surface and composition analysis. These services help customers achieve wear resistance, biocompatibility improvements, drug delivery enhancements, extended implant life and performance, friction reduction, controlled surface adhesion or bonding, sterilisation and infection control.

Surface modification & thermal processing

Plasma modification & thermal processing

Dry film lubrication
Medical applications
Vacuum systems engineering
Contacts, downloads & archive
Home

Carbon based coatings
COATINGS COMMUNITY
LINKEDIN
Follow our team on Linkedin.
Andy Fox
Ian Haggan

Media information
NEWS UPDATES
 Tecvac low friction,  wear resistant and biocompatible surfaces   Call Tecvac on +44 (0) 1954 233700
Biomedical Surfaces  2012

£500,000 EPSRC project at the University of Sheffield
Tecvac Ltd has designed and built a unique, world class surface engineering research machine for The University of Sheffield as part of a £500,000 EPSRC project.

  Specifically designed for the Research Centre in Surface Engineering, led by Professor Allan Matthews (in the Department of Materials Science and Engineering) the new Tecvac IP70 machine uniquely combines two different Physical Vapour Deposition (PVD) coating technologies in a single production scale vacuum chamber.

 Funded by the Engineering and Physical Sciences Research Council (EPSRC), it will be used both for fundamental research and for near-market applications in surface engineering, covering a range of ceramics, nano composite and glassy-metal plasma-based coatings - combined with a duplex substrate diffusion pre-treatment capability.
This will open up routes to new thin film and nano-scale processes which can support innovative medical and life science applications including tissue engineering.
More>>>

Reduced wear & infection
A
new coating developed by Tecvac including silver and chromium nitride has the potential to reduce both wear and joint infection in total hip replacement therapy.
See poster from Queen Mary College, University of London
Project BERTI; (Biomedical implant with Exceptional Resistance to Tribo-bio-corrosion and with Inherent antimicrobial properties) is expected to lead to new designs of  knee and hip implants and  substantially reduce the number of costly revision surgeries for hip and knee replacement patients. Partners in the project include Corin Plc, Tecvac Ltd, Imperial College, University of London, Charing Cross Hospitals, Queen Mary College, University of London and the University of Sheffield.
More>>>
SMART HIP project Tecvac is a partner in the SMART-HIP project which has been funded by the TSB {UK Technology Strategy Board}. "The information we gained earlier  in the DUBIOP   project enabled us to build on our experience and to participate. "  Dr. Jonathan Housden, Head of Research and Development, Tecvac Ltd

Page update February 2012